COMMITMENTS AND CONTINGENCES (Details Narrative) |
3 Months Ended |
|---|---|
|
Jan. 31, 2024
USD ($)
| |
| Research And Development Agreements [Member] | |
| Other Commitments [Line Items] | |
| Payments to acquire research and development | $ 3,600,000 |
| Future payments over period | 5 years |
| Agreement with Wistar Clevel and Clinic [Member] | |
| Other Commitments [Line Items] | |
| Legal license agreement | $ 14,000 |
| X | ||||||||||
- Definition Future payments over period. No definition available.
|
| X | ||||||||||
- Definition Legal license agreement No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|